Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008526
Filing Date
2022-05-12
Accepted
2022-05-12 16:03:12
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmbr-20220331x10q.htm   iXBRL 10-Q 1258671
2 EX-3.1 tmbr-20220331xex3d1.htm EX-3.1 108850
3 EX-31.1 tmbr-20220331xex31d1.htm EX-31.1 17940
4 EX-31.2 tmbr-20220331xex31d2.htm EX-31.2 16224
5 EX-32.1 tmbr-20220331xex32d1.htm EX-32.1 8047
6 EX-32.2 tmbr-20220331xex32d2.htm EX-32.2 9572
  Complete submission text file 0001558370-22-008526.txt   6373158

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmbr-20220331.xsd EX-101.SCH 45774
8 EX-101.CAL tmbr-20220331_cal.xml EX-101.CAL 35272
9 EX-101.DEF tmbr-20220331_def.xml EX-101.DEF 247391
10 EX-101.LAB tmbr-20220331_lab.xml EX-101.LAB 401144
11 EX-101.PRE tmbr-20220331_pre.xml EX-101.PRE 344706
55 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20220331x10q_htm.xml XML 1147856
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 22917686
SIC: 2834 Pharmaceutical Preparations